Compass Therapeutics, Inc. (NASDAQ:CMPX) Given Consensus Rating of “Buy” by Analysts
Shares of Compass Therapeutics, Inc. (NASDAQ:CMPX – Get Free Report) have earned a consensus rating of “Buy” from the nine research firms that are currently covering the firm, MarketBeat reports. Eight research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average twelve-month […]
Shares of Compass Therapeutics, Inc. (NASDAQ:CMPX – Get Free Report) have earned a consensus rating of “Buy” from the nine research firms that are currently covering the firm, MarketBeat reports. Eight research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average twelve-month […]
-logo-1200x675.png?v=20220818172429&w=240&h=240&zc=2){kind=logo}
